immunotherapy
| 2 min read
Asher Bio focuses on cis-targeting technology to precisely target discrete immune cell subtypes
| 4 min read
High tumor mutation burden can predict immunotherapy response only in subset of cancers
| 3 min read
New collaborations will give I-Mab access to cutting edge technology platforms for developing novel drug molecules
| 3 min read
Selexis and BITT enter agreement to advance BITT’s TNFR2 antagonist antibody therapy
| 1 min read
Download this eBook from Drug Discovery News to learn about leading immunotherapy drugs in the pipeline and discover new approaches to immunotherapy drug discovery and delivery.
| 3 min read
Plasmid DNA delivery platform looks promising for metastatic melanoma therapy
| 4 min read
New cancer immunotherapy shows promise in treating cancer
| 2 min read
Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial
| 3 min read
Researchers have published on a new CAR-T cell therapy using CXCR5
